MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on February 15, 2007; DOI: 10.1124/mol.106.033555


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.033555v1
71/5/1268    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
Bradley M Denker
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhu, D.
Right arrow Articles by Denker, B. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhu, D.
Right arrow Articles by Denker, B. M


Received for publication December 15, 2006.
Revised February 13, 2007.
Accepted for publication February 15, 2007.

Domains Necessary for G{alpha}12 Binding and Stimulation of PP2A: is G{alpha} 12 a Novel Regulatory Subunit of PP2A?

Deguang Zhu 1, Robert I Tate 2, Ralf Ruediger 3, Ted E Meigs 2, Bradley M Denker 1*

1 Brigham and Women's Hospital 2 University of North Carolina at Asheville 3 University of California at San Diego

* Address correspondence to: E-mail: bdenker{at}rics.bwh.harvard.edu

Abstract

Many cellular signaling pathways share regulation by PP2A, a widely expressed serine/threonine phosphatase, and the heterotrimeric G protein, G{alpha}12. PP2A activity is altered in carcinogenesis and in some neurodegenerative diseases. We previously identified binding of G{alpha}12 with the A{alpha} subunit of PP2A, a trimeric enzyme composed of A (scaffolding), B (regulatory), and C (catalytic) subunits, and demonstrated G{alpha}12 stimulated phosphatase activity (Zhu et al., 2004 JBC 279; 54983). We now show in substrate-velocity analysis using purified PP2A that Vmax was stimulated 3-4 fold by GST-G{alpha}12 with little effect on Km. To identify the binding domains mediating the A{alpha}-G{alpha}12 interaction, an extensive mutational analysis was performed. Well-characterized mutations of A{alpha} were expressed in vitro and tested for binding to GST-G{alpha}12 in pull-down assays. G{alpha}12 binds to A{alpha} along repeats 7-10, and PP2A B subunits are not necessary for binding. To identify where A{alpha} binds to G{alpha}12, a series of 61 G{alpha}12 mutants were engineered to contain the sequence asn-ala-ala-ile-arg-ser (NAAIRS) in place of 6 consecutive amino acids. Mutant G{alpha}12 proteins were individually expressed in HEK cells, and analyzed for interaction with GST or GST-A{alpha} in pull-downs assays. The A{alpha}binding sites were localized to regions near the N and C terminus of G{alpha}12. The expression of constitutively activated G{alpha}12 (QL{alpha}12) in MDCK cells stimulated PP2A activity as determined by decreased phosphorylation of tyrosine-307 on the catalytic subunit. Based upon crystal structures of G{alpha}12 and PP2A A{alpha}, a model describing the binding surfaces and potential mechanisms of G{alpha}12-mediated PP2A activation is presented.


Key words: G12,13;other G's, Protein Phosphatases (other), Structure-activity relationships and modeling, Mutagenesis/Chimeric approaches


This article has been cited by other articles:


Home page
FASEB J.Home page
A. V. Andreeva, M. A. Kutuzov, and T. A. Voyno-Yasenetskaya
G{alpha}12 is targeted to the mitochondria and affects mitochondrial morphology and motility
FASEB J, August 1, 2008; 22(8): 2821 - 2831.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Yanamadala, H. Negoro, L. Gunaratnam, T. Kong, and B. M. Denker
G{alpha}12 Stimulates Apoptosis in Epithelial Cells through JNK1-mediated Bcl-2 Degradation and Up-regulation of I{kappa}B{alpha}
J. Biol. Chem., August 17, 2007; 282(33): 24352 - 24363.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics